Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein S Mediouni, A Darque, G Baillat, I Ravaux, C Dhiver, H Tissot-Dupont, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2012 | 121 | 2012 |
Targeting HIV transcription: the quest for a functional cure G Mousseau, S Mediouni, ST Valente The Future of HIV-1 Therapeutics: Resistance Is Futile?, 121-145, 2015 | 94 | 2015 |
Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice S Mediouni, J Jablonski, J J Paris, M A Clementz, S Thenin-Houssier, ... Current HIV research 13 (1), 64-79, 2015 | 67 | 2015 |
Didehydro-cortistatin A inhibits HIV-1 by specifically binding to the unstructured basic region of Tat S Mediouni, K Chinthalapudi, MK Ekka, I Usui, JA Jablonski, ... MBio 10 (1), 10.1128/mbio. 02662-18, 2019 | 60 | 2019 |
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders S Mediouni, MC Garibaldi Marcondes, C Miller, JP McLaughlin, ... Frontiers in microbiology 6, 159219, 2015 | 58 | 2015 |
Oregano oil and its principal component, carvacrol, inhibit HIV-1 fusion into target cells S Mediouni, JA Jablonski, S Tsuda, A Barsamian, C Kessing, A Richard, ... Journal of virology 94 (15), 10.1128/jvi. 00147-20, 2020 | 41 | 2020 |
Resistance to the tat inhibitor didehydro-cortistatin a is mediated by heightened basal HIV-1 transcription G Mousseau, R Aneja, MA Clementz, S Mediouni, NS Lima, A Haregot, ... MBio 10 (4), 10.1128/mbio. 01750-18, 2019 | 36 | 2019 |
β-cyclodextrin polymer/Soluplus® encapsulated Ebselen ternary complex (EβpolySol) as a potential therapy for vaginal candidiasis and pre-exposure prophylactic for HIV R Vartak, M Patki, S Menon, J Jablonski, S Mediouni, Y Fu, ST Valente, ... International Journal of Pharmaceutics 589, 119863, 2020 | 32 | 2020 |
Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture Z Yuan, MA Pavel, H Wang, JC Kwachukwu, S Mediouni, JA Jablonski, ... Communications Biology 5 (1), 958, 2022 | 26 | 2022 |
Cell‐Permeable Peptides Containing Cycloalanine Residues H Wu, G Mousseau, S Mediouni, ST Valente, T Kodadek Angewandte Chemie 128 (41), 12827-12832, 2016 | 26 | 2016 |
The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation S Mediouni, CF Kessing, JA Jablonski, S Thenin-Houssier, M Clementz, ... The FASEB Journal 33 (7), 8280, 2019 | 23 | 2019 |
Potent suppression of HIV-1 cell attachment by Kudzu root extract S Mediouni, JA Jablonski, S Tsuda, A Richard, C Kessing, MV Andrade, ... Retrovirology 15, 1-18, 2018 | 22 | 2018 |
Identification of potent small molecule inhibitors of SARS-CoV-2 entry S Mediouni, H Mou, Y Otsuka, JA Jablonski, RS Adcock, L Batra, ... Slas Discovery 27 (1), 8-19, 2022 | 20 | 2022 |
Efavirenz nanomicelles loaded vaginal film (EZ film) for preexposure prophylaxis (PrEP) of HIV M Patki, R Vartak, J Jablonski, S Mediouni, T Gandhi, Y Fu, E Cetindag, ... Colloids and Surfaces B: Biointerfaces 194, 111174, 2020 | 16 | 2020 |
Molecular motor protein KIF5C mediates structural plasticity and long-term memory by constraining local translation S Swarnkar, Y Avchalumov, I Espadas, E Grinman, X Liu, BL Raveendra, ... Cell reports 36 (2), 2021 | 15 | 2021 |
A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade S Mediouni, JD Watkins, M Pierres, A Bole, EP Loret, G Baillat Journal of Biological Chemistry 287 (15), 11942-11950, 2012 | 14 | 2012 |
Forging a functional cure for HIV: transcription regulators and inhibitors S Mediouni, S Lyu, SM Schader, ST Valente Viruses 14 (9), 1980, 2022 | 11 | 2022 |
Next-generation human cerebral organoids as powerful tools to advance NeuroHIV research TA Premeaux, S Mediouni, A Leda, RL Furler, ST Valente, HA Fine, ... MBio 12 (4), 10.1128/mbio. 00680-21, 2021 | 11 | 2021 |
The XPB subunit of the TFIIH complex plays a critical role in HIV-1 transcription, and XPB inhibition by spironolactone prevents HIV-1 reactivation from latency L Mori, K Jenike, YHJ Yeh, B Lacombe, C Li, AJ Getzler, S Mediouni, ... Journal of Virology 95 (4), 10.1128/jvi. 01247-20, 2021 | 11 | 2021 |
Identification of a highly conserved surface on Tat variants S Mediouni, A Darque, I Ravaux, G Baillat, C Devaux, EP Loret Journal of Biological Chemistry 288 (26), 19072-19080, 2013 | 10 | 2013 |